Company intelligence / Profile preview

Curada Bio

Arlington, Massachusetts, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Curada Bio is a private U.S. biotechnology company focused on regenerative medicine for chronic wound care. Publicly available information on the company is limited, but trademark filings indicate it is developing a cell-containing therapeutic product branded COMBICYTE for chronic wound care. The company appears to have been founded in 2022 and is associated with Arlington, Massachusetts. Curada Bio has been identified in third-party sources as a startup co-founded by Omid Veiseh. No clinical-stage programs, marketed products, or major partnerships were clearly documented in readily accessible public sources as of April 9, 2026.

Therapeutic areas: Dermatology
Modalities: Cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Curada Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curada Bio.

Explore the full profile